Synthetic Biologics SYN
$ 0.96
1.32%
Quarterly report 2024-Q3
added 11-12-2024
Synthetic Biologics Cash Flow 2011-2024 | SYN
Annual Cash Flow Synthetic Biologics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-19 M | -19.1 M | -12.9 M | -12.2 M | -13.9 M | -17.3 M | -20.2 M | -27.9 M | -38.9 M | -16.1 M | -7.72 M | -8.92 M | -2.88 M |
Depreciation & Amortization |
135 K | 85 K | 87 K | 201 K | 240 K | 272 K | 245 K | 157 K | 72 K | 20 K | 43 K | 63 K | 144 K |
Accounts Payables |
770 K | 915 K | 524 K | 886 K | 2.32 M | 1.03 M | 2.02 M | 1.99 M | 4.41 M | 996 K | 142 K | 395 K | 388 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | 405 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Synthetic Biologics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.88 M | - | - | - | -5.61 M | - | -13.7 M | -9.26 M | -4.9 M | - | -8.08 M | -5.92 M | -3.33 M | - | -9.04 M | -6.99 M | -4.96 M | - | -10.3 M | -7.21 M | -4.22 M | - | -14 M | -10.4 M | -6.08 M | - | -16.3 M | -11.7 M | -6.01 M | - | -17.5 M | -11.5 M | -5.67 M | - | - | - | -5.46 M | - | -11.3 M | -6.76 M | -3.47 M | - | - | - | -1.66 M | - | -4.14 M | -2.7 M | -1.42 M | - | -2.14 M | -1.23 M | -281 K |
Depreciation & Amortization |
- | - | 39 K | - | - | - | 32 K | - | 60 K | 36 K | 18 K | - | 74 K | 56 K | 33 K | - | 169 K | 116 K | 58 K | - | 182 K | 122 K | 62 K | - | 207 K | 141 K | 71 K | - | 172 K | 116 K | 57 K | - | 111 K | 57 K | 37 K | - | 39 K | 19 K | 8 K | - | 13 K | 7 K | 3 K | - | 33 K | 23 K | 11 K | - | 51 K | 39 K | 20 K | - | 133 K | 101 K | 80 K |
Accounts Payables |
756 K | 935 K | 571 K | 770 K | 833 K | 741 K | 480 K | 915 K | 770 K | 1 M | 1.35 M | 524 K | 1.26 M | 568 K | 621 K | 886 K | 886 K | 886 K | 886 K | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 1.03 M | 1.03 M | 1.03 M | 1.03 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 4.41 M | 4.41 M | 4.41 M | 4.41 M | 996 K | 996 K | 996 K | 996 K | 142 K | 142 K | 142 K | 142 K | 395 K | 395 K | 395 K | 395 K | 388 K | 388 K | 388 K | 388 K |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 122 K | 245 K | 440 K | 405 K | 405 K | 405 K | 405 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency